RT Journal Article
SR Electronic
T1 When to be vaccinated? What to consider? Modelling decision-making and time preference for COVID-19 vaccine through a conjoint experiment approach
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.05.21258416
DO 10.1101/2021.06.05.21258416
A1 Yuen, Samson W.H.
A1 Yue, Ricci P.H.
A1 Lau, Bobo H.B.
A1 Chan, Cecilia L. W.
A1 Ng, Siu-Man
YR 2021
UL http://medrxiv.org/content/early/2021/06/07/2021.06.05.21258416.abstract
AB How do citizens choose COVID-19 vaccines, and when do they wish to be vaccinated? A choice-based conjoint experiment was fielded in Hong Kong to examine factors that shape citizens’ preference toward COVID-19 vaccines and their time preference to be vaccinated, which is overlooked in extant literature. Results suggest people are most concerned about vaccines’ efficacy and severe side-effects, and that cash incentives are not useful in enhancing vaccine appeal. The majority of respondents show low intention for immediate vaccination, and many of them want to delay their vaccination. Further analysis shows that their time preference is shaped more by respondent characteristics than vaccine attributes. In particular, confidence in the vaccine, trust in government, and working in high-risk professions are associated with earlier timing for vaccine uptake. Meanwhile, forced COVID testing would delay vaccination. The findings offer a novel view in understanding how people decide whether and when to receive new vaccines, which have pivotal implications for a head start of any mass vaccination programs.HighlightsPeople are most concerned about vaccines’ efficacy and severe side-effects when choosing COVID-19 vaccinesCash incentives are not useful in enhancing vaccines’ appealTime preference of vaccination is shaped more by respondent characteristics than vaccine attributesForced COVID testing might delay vaccination decisionCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by Innovative Research Grant awarded by the University of Hong Kong to [anonymized].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The research has received ethics approval from the Human Research Ethics Committee of the University of Hong Kong under ref number EA2003003 (March 6, 2020).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData used in this research will be available upon request